Antinuclear Autoantibody‐Negative Systemic Lupus Erythematosus ( SLE ): A Reality or Shortcomings of Diagnostics and Interpretation?
Year: 2025
Type: article
Abstract: This letter highlights the critical need for clinicians to understand antinuclear antibody (ANA) testing methodologies and autoantibody specificities to prevent diagnostic errors and accurately applying classification criteria. Anti-Ro52 is an antinuclear antibody whose detection fulfills the 2019 EULAR/ACR classification entry criterion.
Source: Clinical Case Reports
DOI: 10.1002/ccr3.71415
Institution: Omdurman Islamic University
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,820
OpenAlex ID: W4416227606
